Post-antibiotic effect induced by an antibiotic combination: Influence of altered susceptibility to individual components

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 4, 2005, Pages 583-586

  Li, Ronald C ^a,b   Tang, Mei C ^a  

^a Prince of Wales Hospital   (Hong Kong)

^b International Clin Investigations   (United States)

Author keywords

Gentamicin; Interaction; PAEs; Piperacillin; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; GENTAMICIN; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG POTENTIATION; GENE EXPRESSION; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PSEUDOMONAS AERUGINOSA; RECORDING;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GENTAMICINS; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

EID: 17444415030     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki035     Document Type: Article

References (9)

1. Sader, H. S., Huynh, H. K. & Jones, R. N. (2003). Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and β-lactams tested against gram-negative bacilli. Diagnostic Microbiology and Infectious Disease 47, 547-50.
2. Li, R. C., Schentag, J. J. & Nix, D. E. (1993). The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions. Antimicrobial Agents Chemotherapy 37, 523-31.
3. Sweeney, M. T. & Zurenko, G. E. (2003). In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected gram-negative organisms. Antimicrobial Agents and Chemotherapy 47, 1902-6.
4. Jacqueline, C., Caillon, J., Le Mabecque, V. et al. (2003). In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Journal of Antimicrobial Chemotherapy 51, 857-64.
5. Hostacka, A. (1997). Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa. Arzneimittelforschung 47, 965-7.
6. Totsuka, K., Shiseki, M., Kikuchi, K. et al. (1999). Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. Journal of Antimicrobial Chemotherapy 44, 455-60.
7. Hostacka, A. (1997). In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa. Pharmazie 52, 544-6.
8. National Committee for Clinical Laboratory Standards (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3, M7-A3. NCCLS, Villanova, PA, USA.
9. Fuursted, K. (1988). Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium. Chemotherapy 34, 229-34.